10.74%SPY 129.47 0.65%FNM 7.09 9.41%
The Global Business News Leader | Thursday, 28 Aug 2008
- EQUITY MARKETS
- BONDS AND RATES
- FOREX
- COMMODITIES
- LANGUAGES
- FUNDS
- RETIREMENT
- TAXES
- INSURANCE
- LANGUAGES
- MOVIE
- MUSIC
- TV
- CELEBRITIES
- LANGUAGES
BARR PHARMA INC
BRL (NYSE)
$ 67.65 
Change: +0.07 +0.1% | Volume: 401,740
Change: +0.07 +0.1% | Volume: 401,740
BARR PHARMACEUT - Fundamental Profile
Company Information
| Ticker Symbol: | BRL |
|---|---|
| Exchange: | NYSE |
| Contact Info: | 225 Summit Avenue Montvale NJ 07645 201-930-3300 |
| CEO/President: | Bruce L. Downey |
| Industry: | Medical - Generic Drugs / Standard Industry Code: 2834 |
| Description: | Barr Pharmaceuticals, Inc. is a global specialty pharmaceutical company that operates in more than thirty countries worldwide and is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals and active pharmaceutical ingredients. A holding company, Barr operates through its principal subsidiaries: Barr Laboratories, Inc., Duramed Pharmaceuticals, Inc. and PLIVA d.d. and its subsidiaries. The Company markets more than one hundred and twenty generic and twenty five proprietary products in the U.S. and more than five hundred fifty products globally outside of the U.S. |
Share Information
| Shares Outstanding: | 108,060 (000) | Market Value: | 7,245,630 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 84.74% | Number of Inst.Shareholders: | 5.00% |
| Last Quarter Sales: | 779.00 ($Mil.) | Last Quarter Net Income: | 57.00 ($Mil.) |
| Last Quarter EPS: | 0.64 | P/E Ratio: | 25 |
| Most Recent Earnings: | 0.64 on 08/07/08 | Earnings Per Share: | 1.39 |
| Most Recent Split: | 3-2 on 03/16/04 | Annual Dividend Rate: | 0 |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
Most Popular 
BRL
Companies
IBT
- Unprecedented gold coin demand suggests Asian-style physical metal hoarding spreading to the West
- Precision Drilling falls on Grey Wolf buy
- One PCS potash mine restarts at half rate - two to go
- Precision finally gets Grey Wolf in $2B gas deal
- Brazil's Cosan and US investor team to buy land
- TomoTherapy says FDA OKs radiation technology
- Oil prices rise as Hurricane Gustav nears Gulf
- Madonnas Get Stupid Tour Video Gets Controversial
- Madonna Video in "Sticky & Sweet" Tour Raises Controversy
- Groups Disapprove Madonnas Political Video at "Sticky & Sweet" Tour
- Pixar hiring Michael Keaton to play Barbies Ken in Toy Story 3
- VMAs Hosted by Twilighters Taylor Lautner, Robert Pattinson and Kristen Stewart
- Dancing With the Stars Season 7 Preview
- Breathtaking Jonas Brothers concert in Illinois
Top Competitors
| MYLAN INC |  |
-8.10 | 13.31 |
| TEVA PHARM INDS |  |
+8.90 | 46.87 |
| ALPHARMA INC | |
+45.80 | 35.87 |
| BARR PHARMA INC | |
+16.80 | 67.43 |
| WATSON PHARMACE | |
+3.10 | 29.89 |
Partners  
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives